Esperoct Kit
Product Images NDC 0169-8100

35 FDA label images from Novo Nordisk · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 35 technical images submitted to the FDA as part of the official labeling for Esperoct (NDC 0169-8100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image_overview (Image Overview)

Image_overview (Image Overview)
Illustration depicting the components of the ESPEROCT kit, including a vial with powder, a vial adapter with protective cap and spike, a pre-filled syringe with diluent featuring a syringe cap, scale, and rubber plunger, and a plunger rod with thread and wide top end. Each part is labeled and shown separately for clarity.*
FDA Label Image

Image_a (Image A)

Image_a (Image A)
Illustration showing a pair of hands preparing components of a medication kit, holding a syringe in one hand and a vial in the other, likely demonstrating initial assembly or readiness for injection.*
FDA Label Image

Image_b (Image B)

Image_b (Image B)
An instructional illustration showing a hand gripping a vial and using the thumb to remove the vial's cap with an upward arrow indicating the removal direction.*
FDA Label Image

Image_c (Image C)

Image_c (Image C)
Instructional illustration showing two hands peeling a protective cover off a small vial or container, indicated by an upward arrow. This image appears to be part of a step-by-step guide related to preparation or use of a product kit.*
FDA Label Image

Image-d (Image D)

Image-d (Image D)
An instructional illustration showing a hand removing a sealed vial cap, indicated by a downward arrow pointing towards a vial beneath. This image is likely part of directions for preparing the ESPEROCT kit, which contains antihemophilic factor (recombinant), glycopegylated-exei, by Novo Nordisk.*
FDA Label Image

Image-e (Image E)

Image-e (Image E)
Instructional diagram showing a hand lifting the cap from a vial, with an arrow indicating upward removal. The inset highlights a close-up of the vial's cap before removal, illustrating how to open the vial lid.*
FDA Label Image

Image-f (Image F)

Image-f (Image F)
An instructional illustration showing two hands holding a syringe, with an arrow indicating a twisting motion. This appears to be a step in preparing or assembling a syringe, likely related to the use of ESPEROCT kit components.*
FDA Label Image

Image-g (Image G)

Image-g (Image G)
Illustration showing a step in the assembly or use of a medical device or kit component, where two parts held in hands are being connected, indicated by an arrow pointing from the left part to the right part.*
FDA Label Image

Image-h (Image H)

Image-h (Image H)
An instructional illustration showing two hands connecting or twisting together two components of a medical device or kit, indicated by an arrow pointing upward and a curved arrow suggesting a twisting or locking motion. The top left has a blue square with a white 'H.' The image likely demonstrates part of assembling or preparing the ESPEROCT kit.*
FDA Label Image

Image-i (Image I)

Image-i (Image I)
An instructional illustration showing a hand holding a syringe-like device, with an arrow indicating the motion to push or press the plunger. This image likely demonstrates part of the preparation or administration process for a medical product kit.*
FDA Label Image

Image-j (Image J)

Image-j (Image J)
An instructional illustration depicting a hand holding a syringe and inserting it into a vial within a circular tray, with a curved arrow indicating a circular motion around the vial, likely part of the preparation process for ESPEROCT antihemophilic factor (recombinant), glycopegylated-exei kit by Novo Nordisk.*
FDA Label Image

Image-k (Image K)

Image-k (Image K)
Illustration showing a hand holding a syringe connected to a vial or bottle, with an arrow pointing downward, likely depicting an injection or transfer step for preparation or administration of a medication.*
FDA Label Image

Symbol (Image 14)

FDA Label Image

Esperoct (Overview)

Esperoct (Overview)
An illustration diagram titled 'Overview' showing components of the ESPEROCT kit. It includes labeled images of the vial with ESPEROCT powder featuring a plastic cap and rubber stopper, a vial adapter with protective cap and spike under protective paper, a pre-filled syringe with diluent showing the syringe tip, cap, scale, and rubber plunger, and a plunger rod with thread and wide top end.*
FDA Label Image

Fig. A (Image 18)

Fig. A (Image 18)
Illustration showing a pair of hands holding two separate components of a kit, with the left hand gripping a syringe and the right hand holding a small vial or bottle. The image is likely part of an instructional diagram related to ESPEROCT, antihemophilic factor (recombinant), glycopegylated-exei kit by Novo Nordisk.*
FDA Label Image

Fig. B (Image 19)

Fig. B (Image 19)
An instructional illustration showing a hand holding a vial with the thumb pushing upward on the vial cap, indicating how to remove the cap from the vial. The image has a letter 'B' in the top left corner, suggesting it is part of a step-by-step guide for ESPEROCT kit use.*
FDA Label Image

Fig. C (Image 20)

Fig. C (Image 20)
An instructional illustration showing a pair of hands peeling or lifting the foil lid from a small plastic cup or container, with an upward arrow indicating the direction to remove the lid.*
FDA Label Image

Fig. D (Image 21)

Fig. D (Image 21)
An instructional diagram showing a hand pressing down on a cap or lid above a vial, indicating the action of placing or removing the cap from the vial. The image suggests a step in the preparation or handling of medication but contains no text or detailed instructions.*
FDA Label Image

Fig. E (Image 22)

Fig. E (Image 22)
Instructional illustration showing a hand removing a cap by pulling it upward from a vial or container, likely depicting part of the preparation process for ESPEROCT antihemophilic factor (recombinant), glycopegylated-exei kit by Novo Nordisk.*
FDA Label Image

Fig. F (Image 23)

Fig. F (Image 23)
An instructional illustration showing two hands holding a syringe or similar cylindrical device horizontally, with an arrow indicating a twisting or rotating motion. This likely depicts a step in the preparation or assembly process of the ESPEROCT kit.*
FDA Label Image

Fig. G (Image 24)

Fig. G (Image 24)
Instructional illustration showing two hands opening a small vial or container by twisting off the cap, indicated by an arrow pointing from the closed vial to the open vial. The background is light blue with a blue letter 'G' in the upper left corner.*
FDA Label Image

Fig. H (Image 25)

Fig. H (Image 25)
An instructional illustration showing hands connecting two parts of a medical device or kit, with an arrow indicating the direction of attachment or twisting. The image is related to ESPEROCT, an antihemophilic factor (recombinant), glycopegylated-exei kit by Novo Nordisk.*
FDA Label Image

Fig. I (Image 26)

Fig. I (Image 26)
Illustration showing a hand holding a syringe with an arrow indicating the plunger being pushed. This image appears to be an instructional step related to the preparation or administration of ESPEROCT, an antihemophilic factor (recombinant), glycopegylated-exei kit by Novo Nordisk.*
FDA Label Image

Fig. J (Image 27)

Fig. J (Image 27)
An instructional diagram showing a hand holding a syringe-like device that is being rotated or twisted, indicated by a circular arrow around the device. The image likely depicts a step in the preparation or assembly of the ESPEROCT kit components.*
FDA Label Image

Symbol (Image 28)

FDA Label Image

Fig. K (Image 29)

Fig. K (Image 29)
An instructional illustration showing a hand holding a syringe, with an arrow pointing downward, indicating the action of pushing the plunger. The background is shaded in light blue and contains a small 'K' icon at the top left.*
FDA Label Image

Fig. L (Image 30)

Fig. L (Image 30)
Instructional illustration showing how to connect parts of a syringe or injection device, with a hand holding and twisting a cap or connector onto the syringe barrel, indicated by a curved arrow.*
FDA Label Image

Fig. M (Image 31)

Fig. M (Image 31)
An instructional illustration showing the use of a vial and syringe with a storage container. The image depicts a syringe drawing liquid from a vial, followed by an action of inserting or depositing the syringe into a round container with a multi-slit opening on its lid.*
FDA Label Image

500_iu_carton (Image 32)

500_iu_carton (Image 32)
Packaging label for ESPEROCT 500 IU Kit containing antihemophilic factor (recombinant), glycopegylated-exei. The label shows the product name, strength of 500 IU, kit dosage form, and includes instructions indicating intravenous use after reconstitution. It also notes the inclusion of a vial adapter and pre-filled diluent syringe. The labeler is Novo Nordisk.*
FDA Label Image

1000_iu_carton (Image 33)

1000_iu_carton (Image 33)
Box label for ESPEROCT 1000 IU kit, containing antihemophilic factor (recombinant), glycopegylated-exei. The label indicates it is a plasma derivative for injection after reconstitution. The package includes a vial adapter and pre-filled diluent syringe. Manufactured by Novo Nordisk.*
FDA Label Image

1500_iu_carton (Image 34)

1500_iu_carton (Image 34)
Packaging label for ESPEROCT 1500 IU Kit, a plasma derivative containing antihemophilic factor (recombinant), glycopegylated-exei. The label features dosage strength 1500 IU, usage instructions for intravenous use after reconstitution, and a graphic of a syringe and vial. The product is labeled for single-dose use and includes a vial adapter and pre-filled diluent syringe. Labeler is Novo Nordisk.*
FDA Label Image

2000_iu_carton (Image 35)

2000_iu_carton (Image 35)
ESPEROCT 2000 IU kit packaging label for antihemophilic factor (recombinant), glycopegylated-exei by Novo Nordisk. The label shows product name, strength (2000 IU), dosage form as a kit, and includes instructions for single-dose intravenous use after reconstitution. The label also depicts a vial adapter and pre-filled diluent syringe illustration and includes storage and handling information.*
FDA Label Image

3000_iu_carton (Image 36)

3000_iu_carton (Image 36)
Packaging label for ESPEROCT 3000 IU KIT, containing antihemophilic factor (recombinant), glycopegylated-exei. The label displays the product name, active ingredient, strength (3000 IU), and dosage form as a kit. It includes usage instructions for intravenous use, notes on no preservatives, and mentions components like a vial adapter and pre-filled diluent syringe. The labeler Novo Nordisk is also shown.*
FDA Label Image

4000_iu_carton (Image 15)

4000_iu_carton (Image 15)
The packaging label for ESPEROCT 4000 IU Range, an antihemophilic factor (recombinant), glycopegylated-exei, in a kit dosage form. The label includes product name, strength (4000 IU), and usage instructions for intravenous use after reconstitution. The labeler is Novo Nordisk, with the logo visible. The package also shows a diagram of a vial adapter and pre-filled diluent syringe included in the kit.*
FDA Label Image

5000-iu-carton (5000 Iu Carton)

5000-iu-carton (5000 Iu Carton)
Packaging label for ESPEROCT 5000 IU Range, a kit containing antihemophilic factor (recombinant), glycopegylated-exei. The label shows the proprietary name ESPEROCT in green and blue, identifies the strength as 5000 IU, and specifies it is for intravenous use after reconstitution. The labeler is Novo Nordisk, with instructions mentioning the inclusion of MixPro vial adapter and pre-filled diluent syringe. The label also notes that the product is preservative-free and Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.